Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma

PURPOSE: This study was conducted to evaluate the effectiveness and safety of intensity-modulated radiotherapy (IMRT) and concurrent paclitaxel plus cisplatin (TP regimen) for upper esophageal carcinoma. METHODS: 36 patients of upper esophageal carcinoma were retrospectively analyzed. Patients were...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tu, Lingli, Sun, Lan, Xu, Yong, Wang, Yongsheng, Zhou, Lin, Liu, Yongmei, Zhu, Jiang, Peng, Feng, Wei, Yuquan, Gong, Youling
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3622578/
https://ncbi.nlm.nih.gov/pubmed/23531325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-8-75
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky